1. Buckland, P. R. Will we ever find the genes for addiction? Addiction 103, 1768–1776 (2008).
2. Goldman, D., Oroszi, G. & Ducci, F. The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 6, 521–532 (2005).
3. Bray, N. J. & O’Donovan, M. C. The genetics of neuropsychiatric disorders. Brain Neurosci Adv 2, (2019).
4. Marees, A. T. et al. Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci. Drug Alcohol Depend. 206, 107703 (2020).
5. Scaplen, K. M. & Kaun, K. R. Reward from bugs to bipeds: a comparative approach to understanding how reward circuits function. J. Neurogenet. 30, 133–148 (2016).
6. Martínez-García, F. & Lanuza, E. Evolution of vertebrate survival circuits. Current Opinion in Behavioral Sciences 24, 113–123 (2018).
7. Panksepp, J., Knutson, B. & Burgdorf, J. The role of brain emotional systems in addictions: a neuro-evolutionary perspective and new “self-report” animal model. Addiction 97, 459–469 (2002).
8. Cardoso-Moreira, M. et al. Developmental Gene Expression Differences between Humans and Mammalian Models. Cell Rep. 33, 108308 (2020).
9. Cardoso-Moreira, M. et al. Gene expression across mammalian organ development. Nature 571, 505–509 (2019).
10. Forero, D. A. & González-Giraldo, Y. Convergent functional genomics of cocaine misuse in humans and animal models. Am. J. Drug Alcohol Abuse 46, 22–30 (2020).
11. Huggett, S. B., Bubier, J. A., Chesler, E. J. & Palmer, R. H. C. Do gene expression findings from mouse models of cocaine use recapitulate human cocaine use disorder in reward circuitry? Genes Brain Behav. (2020) doi:10.1111/gbb.12689.
12. Huggett, S. B. & Stallings, M. C. Cocaine’omics: Genome‐wide and transcriptome‐wide analyses provide biological insight into cocaine use and dependence. Addict. Biol. 25, (2020).
13. Ray, P. et al. Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research. Pain 159, 1325–1345 (2018).
14. Olislagers, M., Rademaker, K., Adan, R. A. H., Lin, B. D. & Luykx, J. J. Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders. Mol. Psychiatry 27, 947–955 (2022).
15. Neisewander, J. L., Cheung, T. H. C. & Pentkowski, N. S. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development. Neuropharmacology 76 Pt B, 301–319 (2014).
16. Iversen, S. D. & Iversen, L. L. Dopamine: 50 years in perspective. Trends Neurosci. 30, 188–193 (2007).
17. Walker, D. M. et al. Cocaine Self-administration Alters Transcriptome-wide Responses in the Brain’s Reward Circuitry. Biol. Psychiatry 84, 867–880 (2018).
18. Carpenter, M. D. et al. Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat. Commun. 11, 1–14 (2020).
19. Neisewander, J. L. et al. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J. Neurosci. 20, 798–805 (2000).
20. Tran-Nguyen, L. T. et al. Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19, 48–59 (1998).
21. Grimm, J. W., Hope, B. T., Wise, R. A. & Shaham, Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412, 141–142 (2001).
22. Halbout, B., Bernardi, R. E., Hansson, A. C. & Spanagel, R. Incubation of cocaine seeking following brief cocaine experience in mice is enhanced by mGluR1 blockade. J. Neurosci. 34, 1781–1790 (2014).
23. Alegre-Zurano, L. et al. Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice. Biomed. Pharmacother. 148, 112708 (2022).
24. Mead, A. N., Zamanillo, D., Becker, N. & Stephens, D. N. AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues. Neuropsychopharmacology 32, 343–353 (2007).
25. Gawin, F. H. & Kleber, H. D. Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations. Arch. Gen. Psychiatry 43, 107–113 (1986).
26. Floresco, S. B. The nucleus accumbens: an interface between cognition, emotion, and action. Annu. Rev. Psychol. 66, 25–52 (2015).
27. Andrews, S. FastQC: a quality control tool for high throughput sequence data. URL http://www. bioinformatics. babraham. ac. uk/projects/fastqc (2010).
28. Ewels, P., Magnusson, M., Lundin, S. & Käller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016).
29. Stolarczyk, M., Reuter, V. P., Smith, J. P., Magee, N. E. & Sheffield, N. C. Refgenie: a reference genome resource manager. Gigascience 9, (2020).
30. Patro, R., Duggal, G. & Kingsford, C. Salmon: accurate, versatile and ultrafast quantification from RNA-seq data using lightweight-alignment. https://pdfs.semanticscholar.org/ba81/76f52ca3e8ffc07b6822aa45b5c0096a6649.pdf (2015).
31. Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915 (2019).
32. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
33. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
34. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, 1–9 (2010).
35. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47–e47 (2015).
36. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
37. Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc. 4, 1184–1191 (2009).
38. Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439–3440 (2005).
39. Yang, Z. & Bielawski, J. P. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15, 496–503 (2000).
40. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
41. Melé, M. et al. Human genomics. The human transcriptome across tissues and individuals. Science 348, 660–665 (2015).
42. Bi, R. & Liu, P. Sample size calculation while controlling false discovery rate for differential expression analysis with RNA-sequencing experiments. BMC Bioinformatics 17, 146 (2016).
43. Carlezon, W. A. et al. Regulation of cocaine reward by CREB. Science 282, 2272–2275 (1998).
44. McClung, C. A. & Nestler, E. J. Regulation of gene expression and cocaine reward by CREB and ΔFosB. Nat. Neurosci. 6, 1208–1215 (2003).
45. Gelernter, J. et al. Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol. Psychiatry 19, 717–723 (2014).
46. Powell, G. L. et al. The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats. Biomolecules 10, (2020).
47. Powell, G. L. et al. Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors. Pharmacol. Biochem. Behav. 175, 123–129 (2018).
48. McCrory, E. J. & Mayes, L. Understanding Addiction as a Developmental Disorder: An Argument for a Developmentally Informed Multilevel Approach. Curr Addict Rep 2, 326–330 (2015).
49. Albertson, D. N. et al. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J. Neurochem. 88, 1211–1219 (2004).
50. Albertson, D. N., Schmidt, C. J., Kapatos, G. & Bannon, M. J. Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology 31, 2304–2312 (2006).
51. Muntean, B. S. et al. Members of the KCTD family are major regulators of cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 119, (2022).
52. Teng, X. et al. KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neurosci. Ther. 25, 887–902 (2019).
53. Kuhar, M. J., Jaworski, J. N., Hubert, G. W., Philpot, K. B. & Dominguez, G. Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets. AAPS J. 7, E259-65 (2005).
54. Ong, Z. Y. & McNally, G. P. CART in energy balance and drug addiction: Current insights and mechanisms. Brain Res. 1740, 146852 (2020).
55. Powell, G. L. et al. Environmental enrichment during forced abstinence from cocaine self-administration opposes gene network expression changes associated with the incubation effect. Sci. Rep. 10, (2020).
56. Mukamel, E. A. Multiple Comparisons and Inappropriate Statistical Testing Lead to Spurious Sex Differences in Gene Expression. Biol. Psychiatry (2021) doi:10.1016/j.biopsych.2021.06.026.
57. Geschwind, D. H. & Flint, J. Genetics and genomics of psychiatric disease. Science 349, 1489–1494 (2015).
58. Prom-Wormley, E. C., Ebejer, J., Dick, D. M. & Bowers, M. S. The genetic epidemiology of substance use disorder: A review. Drug Alcohol Depend. 180, 241–259 (2017).
59. Noble, W. S. How does multiple testing correction work? Nat. Biotechnol. 27, 1135–1137 (2009).
60. National Institutes of Health. Types of Grant Programs. https://grants.nih.gov/grants/funding/funding_program.htm (2019).
61. Simoneau, J., Dumontier, S., Gosselin, R. & Scott, M. S. Current RNA-seq methodology reporting limits reproducibility. Brief. Bioinform. 22, 140–145 (2021).